CRISPR THERAPEUTICS LTD earnings per share and revenue

1CG earnings per share for the last quarter are -1.33 EUR whereas the estimation was -1.26 EUR which accounts for -5.08% surprise. Företagets omsättning för samma period uppgår till 467.10 k EUR trots den uppskattade siffran 21.36 M EUR. Estimated earnings per share for the next quarter are -1.32 EUR, and revenue is expected to reach 11.97 M EUR. Also watch annual changes over time to get a bigger picture of 1CG earnings per share and revenue dynamics.